Why is Remus Pharma. falling/rising?

As of 19-Sep, Remus Pharmaceuticals Ltd is currently priced at 801.20, reflecting an increase of 5.25 (0.66%). Despite this uptick, the stock has shown a negative performance over the past week, down 2.36%, and has significantly underperformed over the past month and year, with declines of 12.85% and 33.54%, respectively. The stock is currently trading 3.27% above its 52-week low of Rs 775 and is below its moving averages across various timeframes, indicating a generally bearish trend. However, there has been a notable increase in investor participation, with delivery volume rising by 131.58% compared to the five-day average, suggesting a potential shift in market sentiment, although no specific positive or negative dashboard data is available to further clarify these movements.
In the broader market context, Remus Pharmaceuticals' recent performance contrasts sharply with the benchmark Sensex, which has gained 0.85% over the past week. This divergence highlights the stock's struggle to keep pace with the market, particularly given its year-to-date decline of 35.84% compared to the Sensex's increase of 7.11%. The liquidity of the stock appears adequate for trading, as it meets the threshold for active trading volumes, yet the overall negative returns over multiple periods indicate that investor confidence may still be wavering despite today's modest price increase.